These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7729916)
1. Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease. Desjardins M; Filion LG; Robertson S; Cameron DW Infect Immun; 1995 May; 63(5):2012-20. PubMed ID: 7729916 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid. Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391 [TBL] [Abstract][Full Text] [Related]
3. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. Lagergård T Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843 [TBL] [Abstract][Full Text] [Related]
4. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid. Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191 [TBL] [Abstract][Full Text] [Related]
6. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi. Frisk A; Ahmed HJ; Van Dyck E; Lagergård T Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin M and G antibody response in rabbits after experimental Haemophilus ducreyi infection. Müller F; Müller KH Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):238-44. PubMed ID: 3260705 [TBL] [Abstract][Full Text] [Related]
9. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053 [TBL] [Abstract][Full Text] [Related]
10. Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. Leduc I; Fusco WG; Choudhary N; Routh PA; Cholon DM; Hobbs MM; Almond GW; Orndorff PE; Elkins C Infect Immun; 2011 Aug; 79(8):3168-77. PubMed ID: 21646451 [TBL] [Abstract][Full Text] [Related]
11. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Wising C; Svensson LA; Ahmed HJ; Sundaeus V; Ahlman K; Jonsson IM; Mölne L; Lagergård T Microb Pathog; 2002 Aug; 33(2):49-62. PubMed ID: 12202104 [TBL] [Abstract][Full Text] [Related]
12. Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. Ashby D; Leduc I; Lauzon W; Lee BC; Singhal N; Cameron DW J Immunol Methods; 2005 Apr; 299(1-2):153-64. PubMed ID: 15914198 [TBL] [Abstract][Full Text] [Related]
13. The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid. Fusco WG; Choudhary NR; Routh PA; Ventevogel MS; Smith VA; Koch GG; Almond GW; Orndorff PE; Sempowski GD; Leduc I Vaccine; 2014 Jun; 32(30):3752-8. PubMed ID: 24844153 [TBL] [Abstract][Full Text] [Related]
14. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. Purcell BK; Richardson JA; Radolf JD; Hansen EJ J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485 [TBL] [Abstract][Full Text] [Related]
15. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Campagnari AA; Wild LM; Griffiths GE; Karalus RJ; Wirth MA; Spinola SM Infect Immun; 1991 Aug; 59(8):2601-8. PubMed ID: 1855979 [TBL] [Abstract][Full Text] [Related]
16. Detection of Haemophilus ducreyi lipooligosaccharide by means of an immunolimulus assay. Hansen EJ; Lumbley SR; Saxen H; Kern K; Cope LD; Radolf JD J Immunol Methods; 1995 Sep; 185(2):225-35. PubMed ID: 7561133 [TBL] [Abstract][Full Text] [Related]
17. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid. Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546 [TBL] [Abstract][Full Text] [Related]
18. Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence. Bauer BA; Stevens MK; Hansen EJ Infect Immun; 1998 Sep; 66(9):4290-8. PubMed ID: 9712780 [TBL] [Abstract][Full Text] [Related]
19. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. Fusco WG; Afonina G; Nepluev I; Cholon DM; Choudhary N; Routh PA; Almond GW; Orndorff PE; Staats H; Hobbs MM; Leduc I; Elkins C Infect Immun; 2010 Sep; 78(9):3763-72. PubMed ID: 20584974 [TBL] [Abstract][Full Text] [Related]
20. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi. Alfa MJ; Olson N; Degagne P; Plummer F; Namaara W; Maclean I; Ronald AR J Infect Dis; 1993 May; 167(5):1206-10. PubMed ID: 8486955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]